PNC Financial Services Group’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$956 Sell
1,180
-12
-1% -$10 ﹤0.01% 4574
2025
Q1
$915 Buy
1,192
+1,128
+1,763% +$866 ﹤0.01% 4539
2024
Q4
$82 Hold
64
﹤0.01% 4718
2024
Q3
$132 Hold
64
﹤0.01% 4707
2024
Q2
$244 Buy
+64
New +$244 ﹤0.01% 4635